Nature Reviews Disease Primers
ISSN 2056-676x · Nature Portfolio · United Kingdom · active 1978–2026
Metrics
- Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 38.1
- SJR
- 15.606
- h-index
- 279
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 25 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Nature Reviews Disease Primers is Q1 in Medicine (miscellaneous) (#7 of 2,517 journals).
| Subject category | Quartile | Rank in category |
|---|---|---|
| Medicine (miscellaneous) | Q1 | #7 of 2,517 |
- Cites per document (2 years, Scopus)
- 43.24
- Documents indexed in 2025 (Scopus)
- 98
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Nature Reviews Disease Primers is Q1 in Medicine (miscellaneous) (2025 edition, #7 of 2,517 journals), with SJR 15.606 (Scimago) and an h-index of 279 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- subscription. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Nature Reviews Disease Primers a predatory journal?
Our screening does not flag Nature Reviews Disease Primers. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Nature Reviews Disease Primers indexed in Scopus or Web of Science?
Per our venue index, Nature Reviews Disease Primers appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Nature Reviews Disease Primers?
Papers in Nature Reviews Disease Primers are cited about 38.1 times each within two years of publication, and Scimago places it in Q1, with an h-index of 279. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Nature Reviews Disease Primers (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Nature Reviews Disease Primers is Q1 in Medicine (miscellaneous) (#7 of 2,517 journals). Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Nature Reviews Disease Primers is cited about 38.1 times per paper over two years, with an h-index of 279.
What is the Web of Science (JCR) quartile of Nature Reviews Disease Primers?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Nature Reviews Disease Primers. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Nature Reviews Disease Primers open access?
Our index records its access status as "subscription". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
- The American Journal of Surgical PathologyQ1 · Lippincott Williams & Wilkins
- Multiple Sclerosis JournalQ1 · SAGE Publishing
- HistopathologyQ1 · Wiley
- Archives of Pathology & Laboratory MedicineQ1 · American Medical Association
- Journal of Pathology and Translational MedicineQ1 · Korean Society of Pathologists & the Korean Society for Cytopathology
- Journal of the Japan Society of the Reticuloendothelial SystemQ2
Compare it with its peers: Ranked Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.